(Q44937081)

English

Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

chronic phase chronic myelogenous leukemia

0 references

Hagop Kantarjian

2

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

3

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Alfonso Quintas-Cardama

1

object named as

Alfonso Quintas-Cardama

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

object named as

Mary B Rios

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Guillermo Garcia-Manero

4

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jorge Eduardo Cortes

7

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

6

object named as

Moshe Talpaz

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2592-2597

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical management of patients with chronic myeloid leukemia receiving imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Current management of chemotherapy-induced neutropenia: the role of colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20285

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20285

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44937081&oldid=2058770109"